Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program.
Santoro A, O'Brien ME, Stahel RA, Nackaerts K, Baas P, Karthaus M, Eberhardt W, Paz-Ares L, Sundstrom S, Liu Y, Ripoche V, Blatter J, Visseren-Grul CM, Manegold C. Istituto Clinico Humanitas, Rozzano, Italy. armando.santoro@humanitas.it

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.
Sørensen JB, Frank H, Palshof T. Department Oncology, Finsen Centre/National University Hospital, 9 Blegdamsvej, Copenhagen DK-2100, Denmark. jens.benn.soerensen@rh.regionh.dk

Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Kalmadi SR, Rankin C, Kraut MJ, Jacobs AD, Petrylak DP, Adelstein DJ, Keohan ML, Taub RN, Borden EC. Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. kalmads@ccf.org

[Investigation of allergic reactions to platinum salts]
Touraine F, Sainte Laudy J, Boumediene A, Ndikumwenayo F, Decroisette C, Melloni B, Vergnenegre A, Bonnaud F. Service de Pathologie Respiratoire, CHU de Limoges, Limoges, France.